References
1. Klement G, Huang P, Mayer B, et al. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts. Clin Cancer Res 2002; 8: 221-32.
2. Sugiyama Y, Saji S, Miya K, et al. [Therapeutic effect of multimodal therapy, such as cryosurgery, locoregional immunotherapy and systemic chemotherapy against far advanced breast cancer]. Gan To Kagaku Ryoho 2001; 28: 1616-9.
3. Seroussi B, Bouaud J , Antoine E C. Users' evaluation of OncoDoc, a breast cancer therapeutic guideline delivered at the point of care. Proc AMIA Symp 1999: 384-9.
4. Goldstone R, Itzkowitz S, Harpaz N, et al. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance. Inflamm Bowel Dis 2012; 18: 832-7.
5. Castiglione F, Diaferia M, Morace F, et al. Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy. J Crohns Colitis 2012; 6: 324-9.
6. Florin TH, Pandeya N, Radford-Smith G L. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Gut 2004; 53: 973-9.
7. Gearry RB, Richardson AK, Frampton CM, et al. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010; 25: 325-33.
8. Inoue K, Tabei T, Suemasu K, et al. [Therapeutic efficacy of pirarubicin cyclophosphamide and doxifluridine in advanced and metastatic breast cancer]. Gan To Kagaku Ryoho 1999; 26: 637-42.
9. Alexandre J, Faivre S, Sutherland W, et al. Effects of adjuvant chemotherapy on the natural history and likelihood of therapeutic efficacy in advanced breast cancer patients: a critical literature review. Cancer Treat Rev 1998; 24: 393-406.
10. Valero V, Hortobagyi GN. Primary chemotherapy: a better overall therapeutic option for patients with breast cancer. Ann Oncol 1998; 9: 1151-4.
11. Namer M, Ramaioli A, Hery M, et al. [Prognostic factors and therapeutic strategy of breast cancer]. Rev Prat 1998; 48: 45-51.
12. Samarel N, Fawcett J, Davis MM, et al. Effects of dialogue and therapeutic touch on preoperative and postoperative experiences of breast cancer surgery: an exploratory study. Oncol Nurs Forum 1998; 25: 1369-76.
13. Elstner E, Williamson E A, Zang C, et al. Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells. Breast Cancer Res Treat 2002; 74: 155-65.
14. Huber S, Ulsperger E, Gomar C, et al. Osseous metastases in breast cancer: radiographic monitoring of therapeutic response. Anticancer Res 2002; 22: 1279-88.
15. Byeon JS, Yang SK, Myung SJ, et al. Clinical course of distal ulcerative colitis in relation to appendiceal orifice inflammation status. Inflamm Bowel Dis 2005; 11: 366-71.
16. Perry W B, Opelka F G, Smith D, et al. Discontinuous appendiceal involvement in ulcerative colitis: pathology and clinical correlation. J Gastrointest Surg 1999; 3: 141-4.
17. Yamagishi N, Iizuka B, Nakamura T, et al. Clinical and colonoscopic investigation of skipped periappendiceal lesions in ulcerative colitis. Scand J Gastroenterol 2002; 37: 177-82.
18. Park SH, Loftus EV Jr, Yang SK. Appendiceal Skip Inflammation and Ulcerative Colitis. Dig Dis Sci. 2014 ;59:2050-7.
19. Ko Y, Kariyawasam V, Karnib M, et al. Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia. Clin Gastroenterol Hepatol 2015; 13: 1453-63 e1.
20. Selby W S, Griffin S, Abraham N, et al. Appendectomy protects against the development of ulcerative colitis but does not affect its course. Am J Gastroenterol 2002; 97: 2834-8.
21. Wells G, Shea B, O’connell D, et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
22. Higgins J, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
23. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of appendicectomy on the course of ulcerative colitis. Gut 2002; 51: 803-7.
24. Hallas J, Gaist D, Vach W, et al. Appendicectomy has no beneficial effect on admission rates in patients with ulcerative colitis. Gut 2004; 53: 351-4.
25. Hlavaty T, Toth J, Koller T, et al. Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control study. United European Gastroenterol J 2013; 1: 109-19.
26. Lee HS, Park SH, Yang SK, et al. Appendectomy and the clinical course of ulcerative colitis: a retrospective cohort study and a nested case-control study from Korea. J Gastroenterol Hepatol 2015; 30: 470-7.
27. Lopez-Serrano P, Perez-Calle JL, Perez-Fernandez MT, et al. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand J Gastroenterol 2010; 45: 1464-71.
28. Naganuma M, Iizuka B, Torii A, et al. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001; 96: 1123-6.
29. Naves J E, Lorenzo-Zuniga V, Marin L, et al. Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice. J Gastrointestin Liver Dis 2011; 20: 355-8.
30. Radford-Smith GL, Edwards JE, Purdie DM, et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002; 51: 808-13.
31. Selby WS, Griffin S, Abraham N, et al. Appendectomy protects against the development of ulcerative colitis but does not affect its course. Am J Gastroenterol 2002; 97: 2834-8.
32. Wang YF, Ou-Yang Q, Xia B, et al. Multicenter case-control study of the risk factors for ulcerative colitis in China. World J Gastroenterol 2013; 19: 1827-33.
33. Picazo-Ferrera K, Bustamante-Quan Y, Santiago-Hernandez J, et al. [The role of appendectomy in the ulcerative colitis in Mexico]. Rev Gastroenterol Mex 2011; 76: 316-21.
34. Uzan A, Jolly D, Berger E, et al. [Protective effect of appendectomy on the development of ulcerative colitis. A case-control study]. Gastroenterol Clin Biol 2001; 25: 239-42.
35. Kaplan G G, Jackson T, Sands B E, et al. The Risk of Developing Crohn's Disease After an Appendectomy: A Meta-Analysis. Am J Gastroenterol 2008; 103: 2925-31.
36. Selby W S, Griffin S, Abraham N, et al. Appendectomy protects against the development of ulcerative colitis but does not affect its course. Am J Gastroenterol 2002; 97: 2834-8.